These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22218447)

  • 1. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
    Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB; Silva IN; Pezzuti IL; Januário JN
    Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
    Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
    Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
    J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
    Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
    Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
    Chennuri VS; Mithbawkar SM; Mokal RA; Desai MP
    Indian J Pediatr; 2013 Jan; 80(1):21-5. PubMed ID: 22865354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
    Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
    Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.
    King JL; Naber JM; Hopkin RJ; Repaske DR; Bailey L; Leslie ND
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1038-42. PubMed ID: 11529806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia.
    Pode-Shakked N; Blau A; Pode-Shakked B; Tiosano D; Weintrob N; Eyal O; Zung A; Levy-Khademi F; Tenenbaum-Rakover Y; Zangen D; Gillis D; Pinhas-Hamiel O; Loewenthal N; de Vries L; Landau Z; Rachmiel M; Abu-Libdeh A; Eliakim A; Strich D; Koren I; German A; Sack J; Almashanu S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3172-3180. PubMed ID: 30865229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
    Olgemöller B; Roscher AA; Liebl B; Fingerhut R
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.